Zentalis Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.

About ZNTL

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations.

CEO

Julia Marie Eastland

CEOJulia Marie Eastland

Employees

166

Employees166

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2014

Founded2014

Employees

166

Employees166

ZNTL Key Statistics

Market cap

85.62M

Market cap85.62M

Price-Earnings ratio

-0.39

Price-Earnings ratio-0.39

Dividend yield

—

Dividend yield—

Average volume

642.54K

Average volume642.54K

High today

$1.22

High today$1.22

Low today

$1.19

Low today$1.19

Open price

$1.22

Open price$1.22

Volume

198.17K

Volume198.17K

52 Week high

$13.00

52 Week high$13.00

52 Week low

$1.01

52 Week low$1.01

Analyst ratings

56%

of 9 ratings

Buy

44.4%

Hold

55.6%

Sell

People also own

Based on the portfolios of people who own ZNTL. This list is generated using Robinhood data, and it’s not a recommendation.